Inflammation-triggering cellular pathway identified as potential new drug target for Alzheimer’s disease

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers cellular inflammation and aging and is linked to Alzheimer’s disease, particularly among those who carry the APOE4 genetic risk. They have also found a way to return cells to a healthy state, revealing a new potential approach to treatment.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup